1. Zebrafish Developmental Models of Skeletal Diseases. Luderman LN, Unlu G, Knapik EW (2017) Curr Top Dev Biol : 81-124
    › Primary publication · 28335865 (PubMed)
  2. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo. Lavender N, Yang J, Chen SC, Sai J, Johnson CA, Owens P, Ayers GD, Richmond A (2017) BMC Cancer 17(1): 88
    › Primary publication · 28143493 (PubMed) · PMC5286656 (PubMed Central)
  3. The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease. Xie LJ, Cui Z, Chen FJ, Pei ZY, Hu SY, Gu QH, Jia XY, Zhu L, Zhou XJ, Zhang H, Liao YH, Lai LH, Hudson BG, Zhao MH (2017) Immunology
    › Primary publication · 28342268 (PubMed)
  4. The ROCK isoforms differentially regulate the morphological characteristics of carcinoma cells. Jerrell RJ, Leih MJ, Parekh A (2017) Small GTPases
    › Primary publication · 28650698 (PubMed)
  5. The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease. Kralisch S, Hoffmann A, Klöting N, Bachmann A, Kratzsch J, Blüher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T (2017) Diabetes Metab
    › Primary publication · 28214129 (PubMed)
  6. The Innate Immune Response in Fetal Lung Mesenchymal Cells Targets VEGFR2 Expression and Activity. Medal RM, Im AM, Yamamoto Y, Lakhdari O, Blackwell TS, Hoffman HM, Sahoo D, Prince LS (2017) Am J Physiol Lung Cell Mol Physiol : ajplung.00554.2016
    › Primary publication · 28336813 (PubMed)
  7. Strategies to overcome therapeutic resistance in renal cell carcinoma. Siska PJ, Beckermann KE, Rathmell WK, Haake SM (2017) Urol Oncol 35(3): 102-110
    › Primary publication · 28089416 (PubMed) · PMC5318278 (PubMed Central)
  8. Spatial distributions of glutathione and its endogenous conjugates in normal bovine lens and a model of lens aging. Nye-Wood MG, Spraggins JM, Caprioli RM, Schey KL, Donaldson PJ, Grey AC (2017) Exp Eye Res : 70-78
    › Primary publication · 27838309 (PubMed) · PMC5359059 (PubMed Central)
  9. Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer. Arnold Egloff SA, Du L, Loomans HA, Starchenko A, Su PF, Ketova T, Knoll PB, Wang J, Haddad AQ, Fadare O, Cates JM, Lotan Y, Shyr Y, Clark PE, Zijlstra A (2017) Oncotarget 8(1): 722-741
    › Primary publication · 27894096 (PubMed)
  10. Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making? Haake SM, Rathmell WK (2017) Cancer 123(2): 200-209
    › Primary publication · 27861752 (PubMed) · PMC5222778 (PubMed Central)